Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

64.78
+0.04000.06%
Post-market: 64.780.00000.00%17:38 EST
Volume:454.09K
Turnover:29.43M
Market Cap:6.17B
PE:26.22
High:65.28
Open:64.80
Low:64.01
Close:64.74
52wk High:84.15
52wk Low:60.14
Shares:95.25M
Float Shares:60.41M
Volume Ratio:0.58
T/O Rate:0.75%
Dividend:1.38
Dividend Rate:2.13%
EPS(TTM):2.47
EPS(LYR):2.62
ROE:9.46%
ROA:5.27%
PB:2.38
PE(LYR):24.73

Loading ...

Dolby Laboratories Inc. to Release Q1 Fiscal 2026 Financial Results

Reuters
·
Jan 14

Assessing Dolby Laboratories (DLB) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jan 10

Dolby Unveils Next-Gen Entertainment Innovations at CES 2026

Reuters
·
Jan 06

Dolby SVP John D. Couling Reports Sale of Common Shares

Reuters
·
Dec 16, 2025

How Dolby’s New Home and In‑Car Atmos Experiences Could Reshape the DLB Competitive Narrative

Simply Wall St.
·
Dec 06, 2025

Dolby EVP Mark Andrew Sherman Reports Sale of Common Shares

Reuters
·
Dec 04, 2025

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

GlobeNewswire
·
Dec 03, 2025

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

GlobeNewswire
·
Dec 02, 2025

Dolby Laboratories (DLB): Exploring Valuation as Shares Recover from Tougher Stretch Earlier This Year

Simply Wall St.
·
Dec 02, 2025

Director Tony A. Prophet Reports Sale of Dolby Laboratories Inc. Common Shares

Reuters
·
Nov 27, 2025

Dolby Laboratories SVP John D. Couling Reports Sale of Common Shares

Reuters
·
Nov 25, 2025

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire
·
Nov 24, 2025

Research Reports -- Barrons.com

Dow Jones
·
Nov 22, 2025

Dolby Laboratories Navigates Complex Tech Standards Amid Shifting Broadcast and Internet Landscapes

TIPRANKS
·
Nov 20, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet

Reuters
·
Nov 20, 2025

Dolby Partners with Bay Area Host Committee for Super Bowl LX Innovation Summit

Reuters
·
Nov 20, 2025

Dolby Laboratories Is Maintained at Outperform by Barrington Research

Dow Jones
·
Nov 19, 2025

Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating

MT Newswires Live
·
Nov 19, 2025

Dolby Laboratories Inc : Rosenblatt Securities Cuts Target Price to $85 From $95

THOMSON REUTERS
·
Nov 19, 2025

Strategic Advancements and Growth Potential Drive Buy Rating for Dolby Laboratories

TIPRANKS
·
Nov 19, 2025